Diabetes Specialists Call For Drug Regulators To Step In To Clarify Lantus Concerns, UK
Diabetes Specialists Call For Drug Regulators To Step In To Clarify Lantus Concerns, UK
BRITAIN'S top diabetes specialists added their weight to calls for European drug regulatory bodies to launch an urgent investigation into the popular insulin treatment glargine (Lantus). The move by the Association of British Clinical Diabetologists (ABCD) follows this week's publication of four studies, which raise possible concern about an increased risk of the development of cancer in people who use this long-acting insulin therapy.